EFFICACY OF VENLAFAXINE AND METHYLPHENIDATE IN THE TREATMENT OF CHILDREN WITH ATTENTION DEFICIT HYPERACTIVITY DISORDER

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

FIROUZ KOUHI MOGHADAM M.; ARABGOL F.; RAJEZI S.; SHAMS J.

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Zahedan Journal of Research in Medical Sciences Year:2008 | Volume:10 | Issue:2 Page(s): 69-77

Download Full-Text

Persian Verion

View:

3,485

Download:

Cites:

Information Journal Paper

Title

EFFICACY OF VENLAFAXINE AND METHYLPHENIDATE IN THE TREATMENT OF CHILDREN WITH ATTENTION DEFICIT HYPERACTIVITY DISORDER

Author(s)

FIROUZ KOUHI MOGHADAM M. | ARABGOL F. | RAJEZI S. | SHAMS J. | Issue Writer Certificate

Keywords

ATTENTION DEFICIT HYPERACTIVITY DISORDERQ3

CHILDRENQ3

VENLAFAXINEQ2

METHYLPHENIDATEQ2

Abstract

Background: The role of noradrenergic system is strongly considered in etiology and treatment of ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD). Regarding the role of norepinephrin and serotonin neurotransmitters in activity and attention control processes, this study was performed to compare effectiveness of VENLAFAXINE and METHYLPHENIDATE in the treatment of ADHD.Materials and Methods: Forty CHILDREN with ADHD (aged 6-12) were randomly allocated to receive VENLAFAXINE or METHYLPHENIDATE in a 6-week clinical trial in Emam-Hossein Hospital. There were no significant differences between groups for age, weight, type and severity of the disorder. Based on DSM-IV criteria and ADHD Rating Scale, patients were diagnosed as having combined and inattentive types of ADHD. Treatment outcome was assessed using parent and teacher versions of ADHD Rating Scale in weeks 2, 4 and 6.Results: There was a statistically significant decrease in ADHD Rating Scale scores and clinical improvement in each group and there was significant difference between two groups. The most common adverse effects in VENLAFAXINE group were nausea, sedation, dry mouth and dizziness. Conclusion: VENLAFAXINE is effective in treatment of CHILDREN with ADHD and could be used as a safe drug in these CHILDREN; though further studies with greater sample sizes are needed to confirm these results.

Cites

A COMPREHENSIVE META-ANALYSIS OF THE COMMON INTERVENTIONS IN ADHD

References

No record.

Cite

APA: Copy

FIROUZ KOUHI MOGHADAM, M., ARABGOL, F., RAJEZI, S., & SHAMS, J.. (2008). EFFICACY OF VENLAFAXINE AND METHYLPHENIDATE IN THE TREATMENT OF CHILDREN WITH ATTENTION DEFICIT HYPERACTIVITY DISORDER. ZAHEDAN JOURNAL OF RESEARCH IN MEDICAL SCIENCES (TABIB-E-SHARGH), 10(2), 69-77. SID. https://sid.ir/paper/84487/en

Vancouver: Copy

FIROUZ KOUHI MOGHADAM M., ARABGOL F., RAJEZI S., SHAMS J.. EFFICACY OF VENLAFAXINE AND METHYLPHENIDATE IN THE TREATMENT OF CHILDREN WITH ATTENTION DEFICIT HYPERACTIVITY DISORDER. ZAHEDAN JOURNAL OF RESEARCH IN MEDICAL SCIENCES (TABIB-E-SHARGH)[Internet]. 2008;10(2):69-77. Available from: https://sid.ir/paper/84487/en

IEEE: Copy

M. FIROUZ KOUHI MOGHADAM, F. ARABGOL, S. RAJEZI, and J. SHAMS, “EFFICACY OF VENLAFAXINE AND METHYLPHENIDATE IN THE TREATMENT OF CHILDREN WITH ATTENTION DEFICIT HYPERACTIVITY DISORDER,” ZAHEDAN JOURNAL OF RESEARCH IN MEDICAL SCIENCES (TABIB-E-SHARGH), vol. 10, no. 2, pp. 69–77, 2008, [Online]. Available: https://sid.ir/paper/84487/en

Related Journal Papers